ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 616,19
-0,60%
Dow Jones
39 042,59
-0,18%
DAX
18 153,15
-0,05%
Brent Oil
84,43
0,29%
Bitcoin
61 585,76
-0,36%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. OpGen Inc (OPGN)

  7. OpGen Inc (OPGN) Actualités

OPGN

OpGen (OPGN)

OpGen Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateHeureSourceTitreSymboleSociété
11/06/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPGNOpGen Inc
30/05/202422h30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:OPGNOpGen Inc
24/05/202422h05GlobeNewswire Inc.OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-QNASDAQ:OPGNOpGen Inc
17/05/202423h02Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:OPGNOpGen Inc
16/05/202413h00GlobeNewswire Inc.OpGen Announced 1-for-10 Reverse Stock SplitNASDAQ:OPGNOpGen Inc
29/04/202422h05GlobeNewswire Inc.OpGen Provides Update on Business Operations and Strategic OpportunitiesNASDAQ:OPGNOpGen Inc
23/04/202422h15GlobeNewswire Inc.OpGen Receives Nasdaq Notice Regarding Delayed Form 10-KNASDAQ:OPGNOpGen Inc
26/03/202421h20AllPennyStocks.comShares Rip In Reaction To Activist Investor Becoming CEONASDAQ:OPGNOpGen Inc
25/03/202421h05GlobeNewswire Inc.OpGen Announces Acquisition of Preferred Stock by David LazarNASDAQ:OPGNOpGen Inc
24/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OPGNOpGen Inc
14/11/202322h30GlobeNewswire Inc.OpGen Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
13/11/202322h59Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OPGNOpGen Inc
13/10/202323h18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPGNOpGen Inc
13/10/202323h17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OPGNOpGen Inc
12/10/202318h32GlobeNewswire Inc.OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross ProceedsNASDAQ:OPGNOpGen Inc
28/09/202322h24Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:OPGNOpGen Inc
14/08/202314h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPGNOpGen Inc
10/08/202322h15GlobeNewswire Inc.OpGen Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
07/08/202313h30GlobeNewswire Inc.OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud OfferingNASDAQ:OPGNOpGen Inc
03/08/202314h00GlobeNewswire Inc.OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration AgreementNASDAQ:OPGNOpGen Inc
03/08/202313h30GlobeNewswire Inc.OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern TimeNASDAQ:OPGNOpGen Inc
01/08/202315h40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPGNOpGen Inc
21/07/202322h55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPGNOpGen Inc
19/07/202313h30GlobeNewswire Inc.OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FINDNASDAQ:OPGNOpGen Inc
14/07/202322h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:OPGNOpGen Inc
26/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
26/06/202313h30GlobeNewswire Inc.OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in EuropeNASDAQ:OPGNOpGen Inc
22/06/202313h30GlobeNewswire Inc.OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 InstrumentsNASDAQ:OPGNOpGen Inc
20/06/202313h30GlobeNewswire Inc.OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 ConferenceNASDAQ:OPGNOpGen Inc
09/06/202322h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN

Dernières Valeurs Consultées

ASX
MMMDA
Marley Spoon
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés